Skip to main content
SpringerLink
Log in

Topical fluticasone: an effective corticosteroid with minimal systemic effects

  • New Drugs and Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Spencer CM, Wiseman LR. Topical fluticasone propionate: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. BioDrugs 1997; 7(4): 318–334

    Article  PubMed  CAS  Google Scholar 

  2. Delescluse J, van der Endt JD. A comparison of the safety, tolerability, and efficacy of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of eczema. Cutis 1996 Feb; 57: 32–8

    PubMed  CAS  Google Scholar 

  3. Roberts DT. Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis. Cutis 1996 Feb; 57: 27–31

    PubMed  CAS  Google Scholar 

  4. Juhlin L. Comparison of fluticasone propionate cream, 0.05%, and hydrocortisone-17-butyrate cream, 0.1%, in the treatment of eczema. Cutis 1996 Feb; 57: 51–6

    PubMed  CAS  Google Scholar 

  5. Dykes PJ, Marks R, Hill S, et al. The kinetics of skin thinning induced by topical fluticasone propionate 0.05% cream in volunteer subjects. Clin Exp Dermatol 1996; 21: 180–4

    Article  PubMed  CAS  Google Scholar 

  6. Kennedy CTC, Helm K, Birchall NM, et al. Fluticasone propionate 0.05% cream for atopic dermatitis in children (poster). Presented at the World Congress of Dermatology; 1992 Jun 12–18; New York

    Google Scholar 

  7. Bleehen SS, Chu AC, Hamann I, et al. Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment. Br J Dermatol 1995 Oct; 133: 592–7

    Article  PubMed  CAS  Google Scholar 

  8. Callen J. Comparison of safety and efficacy of fluticasone propionate cream, 0.05%, and betamethasone valerate cream, 0.1%, in the treatment of moderate-to-severe psoriasis. Cutis 1996 Feb; 57: 45–50

    PubMed  CAS  Google Scholar 

  9. Nurnberber FG. A comparison of fluticasone propionate ointment, 0.005%, and hydrocortisone-17-butyrate ointment, 0.01%, in the treatment of psoriasis. Cutis 1996 Feb; 57: 39–44

    Google Scholar 

  10. PDR Generics. 3rd ed. Montvale NJ: Medical Economics, 1997: 382, 383, 1404, 1640

  11. Monroe EW. The McKenzie vasoconstriction assay: rethinking its use for intranasal topical corticosteroids. Advances in Therapy 1996 Jul–Aug; 13: 237–43

    CAS  Google Scholar 

  12. British National Formulary No. 33. London: The Pharmaceutical Press, 1997 Mar: 467, 468, 471

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Topical fluticasone: an effective corticosteroid with minimal systemic effects. Drugs Ther. Perspect 10, 1–4 (1997). https://doi.org/10.2165/00042310-199710120-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199710120-00001

Keywords

Search

Navigation